Regional Disparities in Qualified Health Plans’ Prior Authorization Requirements for HIV Pre-exposure Prophylaxis in the United States | Zendy

Kathleen A. McManus | Zendy; Samuel Powers | Zendy; Amy Killelea | Zendy; Sebastian TelloTrillo | Zendy; Elizabeth Rogawski McQuade | Zendy

Open Access

Regional Disparities in Qualified Health Plans’ Prior Authorization Requirements for HIV Pre-exposure Prophylaxis in the United States

Author(s) -

Kathleen A. McManus,

Samuel Powers,

Amy Killelea,

Sebastian TelloTrillo,

Elizabeth Rogawski McQuade

Publication year - 2020

Publication title -

jama network open

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.278

H-Index - 39

ISSN - 2574-3805

DOI - 10.1001/jamanetworkopen.2020.7445

Subject(s) - emtricitabine , prior authorization , tenofovir , pharmacy , pre exposure prophylaxis , medicine , lagging , environmental health , human immunodeficiency virus (hiv) , family medicine , antiretroviral therapy , pharmacology , men who have sex with men , viral load , syphilis , pathology

This cross-sectional study investigates whether there are regional disparities in prior authorization requirements for combined tenofovir disoproxil fumarate and emtricitabine with qualified health plans and assesses if any qualified health plan characteristics explain the disparities.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research